Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: M0NEYMADE who wrote (138373)	9/17/2004 4:00:04 PM
From: M0NEYMADE	Respond to of 150070

,,,,,,,UGHO congrats. :-(

To: M0NEYMADE who wrote (138373)	9/17/2004 4:13:39 PM
From: Supervalue	Read Replies (1) \| Respond to of 150070

Alot of smoking has to be neutralized from diet habits

To: M0NEYMADE who wrote (138373)	9/17/2004 5:38:43 PM
From: StocksDATsoar	Respond to of 150070

I SMOKE 2 PACKS..PLUS OTHER THINGS ;-( I BETTER QUIT.

To: M0NEYMADE who wrote (138373)	9/18/2004 6:32:21 AM
From: lakers17	Respond to of 150070

54 years old and smoking three packs a day? One pack would be bad enough. Isn't that a little excessive? What did he expect. good shape? Was the guy jogging or doing cardio smoking three packs a day? Fast food, obesity, cigs, and stress are killing a lot of people or causing life long health problems. It's a no brainer. We are one fat lazy country for the most part.

To: M0NEYMADE who wrote (138373)	9/19/2004 9:06:10 AM
From: StocksDATsoar	Read Replies (1) \| Respond to of 150070

THIS WAS IN MY EMAIL THIS AM. Subj: If you miss out on this opportunity you will hate youself sqr kmn mnvn oaredq ixq vrgk ejmi Date: 9/19/04 12:41:29 AM Eastern Daylight Time From: VeryHotStockPickspdou84@highuintapackgoats.com Sent from the Internet (Details) H$HL H$HL H$HL H$HL H$HL H$HL H$HL H$HL H$HL Your Just one out of 50 million that will recieve this message just imagine the potential. Set to explode on monday Sept 20 Home Solutions Health Inc. (OTC: "HSHL" .06) is an emerging player in the $1 BILLION Dollar hemorrhoidal treatment market. HSHL's NEW FDA-approved proprietary device is discreet selling like hot cakes and proven 90% affective in early trials. As SEEN on E! & Howard Stern. JULY SALES up 400%! AUGUST SALES PR COMING ANY DAY! GRAB A POSITION BEFORE THE MONSTER RELEASE. HUGE RECOGNITION FROM BEING ON CABLE NETWORK E! ENTERTAINMENT HOWARD STERN & WABC RADIO...HOME OF THE (GOP) NATIONAL REPUBLICAN CONVENTION...WABC RADIO is the most listened to NEWS radio network. Symbol Pink Sheets: HSHL Current Price: $0.06 7 Day Price Trend: Upward ($0.12 - $0.27) Recommendation: AGRESSIVE; BUY OPPORTUNITY ASSESMENT HSHL presents an exciting opportunity to invest early in a company that offers a unique and effective treatment for an embarrassing and painful medical condition which afflicts millions of Americans. The Companyâ€™s patented FDA-approved medical device provides a more effective treatment solution than any other medical product currently on the market. Its one of the most revolutionary products of its time in the health care industry. Statistics show that an astounding 55% of men over forty and 50% of women over thirty who have born children will develop hemorrhoids at least once in their lifetime with over 3.5 million cases treated by doctors every year! This excludes the many sufferers who remain silent to avoid the embarrassment of doctor visits and purchasing remedies from a drug store. Often this excruciating and chronic condition requires invasive and painful treatments including surgery resulting in long recovery periods and debilitation. HSHL is the first company to offer a safe reusable and painless non-chemical treatment proven to relieve symptoms in over 90% of patients. The current US demand for hemorrhoid relief products is estimated at 30 million people; representing a market of over $1 billion. Incidence rate indicates massive 10% growth per year! With only 5% of this market HSHL could reach $45 M in revenues over the near term!!!! Leading stocks offering symptom relieving solutions are beginning to see tremendous growth; while HSHL begins to see major sales as its â€œHemorreliefâ€ product continues to gain excellent reputation through successful clinical studies! NICHE MARKET GROWTH The $1 trillion health care industry is beginning to recognize the commercial viability of developing treatments for hemorrhoids and biotech companies which have developed products in the pipeline are beginning to see major price increases!! Cellergy Pharmaceuticals (CLGY) has seen its share price increase up to 130% over the last six months as it develops its hemorrhoid treatment products!!! We believe that HSHL is poised to see this type of growth!!! H$HL H$HL H$HL H$HL H$HL H$HL H$HL H$HL H$HL Information within this email contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions goals expectations beliefs plans projections objectives assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." Forward looking statements are based on expectations estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as: "projects" foresee expects estimates believes understands will anticipates or that by statements indicating certain actions "may could or might" occur. All information provided within this email pertaining to investing stocks securities must be understood as information provided and not investment advice. Emerging Equity Alert advises all readers and subscribers to seek advice from a registered professional securities representative before deciding to trade in stocks featured within this email. None of the material within this report shall be construed as any kind of investment advice. In compliance with Section 17(b) we disclose the holding of shares of HSHL prior to the publication of this report. Be aware of an inherent conflict of interest resulting from such holdings due to our intent to profit from the liquidation of these shares. Shares may be sold at any time even after positive statements have been made regarding the above company.